JP2010525033A5 - - Google Patents

Download PDF

Info

Publication number
JP2010525033A5
JP2010525033A5 JP2010504743A JP2010504743A JP2010525033A5 JP 2010525033 A5 JP2010525033 A5 JP 2010525033A5 JP 2010504743 A JP2010504743 A JP 2010504743A JP 2010504743 A JP2010504743 A JP 2010504743A JP 2010525033 A5 JP2010525033 A5 JP 2010525033A5
Authority
JP
Japan
Prior art keywords
insulin
aqueous solution
less
hexamer
zinc ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010504743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010525033A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/055341 external-priority patent/WO2008132229A2/en
Publication of JP2010525033A publication Critical patent/JP2010525033A/ja
Publication of JP2010525033A5 publication Critical patent/JP2010525033A5/ja
Withdrawn legal-status Critical Current

Links

JP2010504743A 2007-04-30 2008-04-30 高濃縮のインスリン溶液及び組成物 Withdrawn JP2010525033A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07107221 2007-04-30
EP07109906 2007-06-08
EP07117798 2007-10-03
PCT/EP2008/055341 WO2008132229A2 (en) 2007-04-30 2008-04-30 Highly concentrated insulin solutions and compositions

Publications (2)

Publication Number Publication Date
JP2010525033A JP2010525033A (ja) 2010-07-22
JP2010525033A5 true JP2010525033A5 (enExample) 2014-09-18

Family

ID=39495516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504743A Withdrawn JP2010525033A (ja) 2007-04-30 2008-04-30 高濃縮のインスリン溶液及び組成物

Country Status (4)

Country Link
US (1) US20100120660A1 (enExample)
EP (2) EP2514412A1 (enExample)
JP (1) JP2010525033A (enExample)
WO (1) WO2008132229A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー/エス プロテアーゼ耐性のインスリンアナログ
ES2563038T3 (es) 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
CN101970477B (zh) * 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
JP5749155B2 (ja) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー/エス プロテアーゼ安定化アシル化インスリンアナログ
UA108475C2 (uk) * 2009-07-31 2015-05-12 Санофі-Авентіс Дойчланд Гмбх Композиція інсуліну тривалої дії
US10842951B2 (en) 2010-01-12 2020-11-24 Aerami Therapeutics, Inc. Liquid insulin formulations and methods relating thereto
US9180261B2 (en) 2010-01-12 2015-11-10 Dance Biopharm Inc. Preservative free insulin formulations and systems and methods for aerosolizing
WO2011161427A2 (en) * 2010-06-25 2011-12-29 Aston University Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
WO2012074989A2 (en) * 2010-11-30 2012-06-07 Joslin Diabetes Center, Inc. Compositions and methods for the treatment of nervous disorders associated with diabetes
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
CN103930096B (zh) * 2011-10-31 2017-05-31 Xeris药物公司 用于治疗糖尿病的制剂
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US20140179597A1 (en) * 2012-11-16 2014-06-26 Steven Lehrer Method for the treatment and prevention of Alzheimer's disease and central nervous system dysfunction
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
ES2676065T3 (es) 2013-10-07 2018-07-16 Novo Nordisk A/S Nuevo derivado de un análogo de la insulina
WO2016022831A1 (en) 2014-08-06 2016-02-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
HK1245116A1 (zh) 2015-02-25 2018-08-24 Dance Biopharm Inc. 液体胰岛素制剂及与其相关的方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
EP3442998A4 (en) 2016-04-12 2020-04-01 Cell And Molecular Tissue Engineering, LLC SYSTEMS, METHODS AND PRODUCTS FOR MINIMIZING TISSUE REACTIONS AND TISSUE DAMAGE AT AN INFUSION SITE
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
HUE060149T2 (hu) * 2016-12-16 2023-02-28 Novo Nordisk As Inzulint tartalmazó gyógyászati készítmények
EP3630061B1 (en) 2017-06-02 2024-04-03 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
US11478534B1 (en) * 2021-07-13 2022-10-25 America Great Health Formulation and method of preparing zinc-charged insulin for oral administration
US20230025595A1 (en) * 2021-07-13 2023-01-26 America Great Health, a California Corporation Formulation and Method of Preparing Divalent Cation Charged Insulin for Oral Administration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
NZ223630A (en) * 1987-02-25 1989-11-28 Novo Industri As Insulin derivative and pharmaceutical compositions
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
ES2230727T3 (es) * 1997-11-12 2005-05-01 Alza Corporation Procedimiento de administracion dermal de polipeptidos.
PT1121144E (pt) * 1998-10-16 2002-11-29 Novo Nordisk As Preparados de insulina concentrada estavel para administracao pulmonar
US6489292B1 (en) * 1998-11-18 2002-12-03 Novo Nordisk A/S Stable aqueous insulin preparations without phenol and cresol
JP2002529514A (ja) * 1998-11-18 2002-09-10 ノボ ノルディスク アクティーゼルスカブ フェノール及びクレゾールを要さない安定なインスリン水性調製物
JP3799924B2 (ja) 2000-01-11 2006-07-19 株式会社日立製作所 電力用遮断器および発電所電気回路装置
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
EP1951198B1 (en) * 2005-10-20 2010-06-16 MDRNA, Inc. Intranasal administration of rapid acting insulin
ES2563038T3 (es) * 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca

Similar Documents

Publication Publication Date Title
JP2010525033A5 (enExample)
Denis et al. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.
RU2470016C2 (ru) Производное бипиразола
RU2470642C2 (ru) Аналоги птерина для лечения состояния, чувствительного к вн4
JP2013519632A5 (enExample)
US20230128449A1 (en) Silicate containing compositions and methods of treatment
JP2019515908A5 (enExample)
RU2016147575A (ru) Непрерывное введение l-допа, ингибиторов допа-декарбоксилазы, ингибиторов катехол-о-метилтрансферазы и предназначенные для этого композиции
JP2011502997A5 (enExample)
JP2010525033A (ja) 高濃縮のインスリン溶液及び組成物
RU2013119966A (ru) Композиция, улучшающая растворимость плохорастворимого лекарственного препарата
JPWO2010041647A1 (ja) アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤
RU2004101229A (ru) Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения
CA2337484A1 (en) Fatty acid-containing composition
RU2011130508A (ru) Рецептура для перорального трансмукозального применения гиполипидемических лекарственных средств
ES2553107T3 (es) Composición anti-inflamatoria basada en compuestos de estroncio
CN1061415A (zh) 含s(+)-苯基链烷酸和氨基糖类的配合物
CA2565993A1 (en) Salt of 4-or 5- aminosalicylic acid
RU2012104639A (ru) Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости
JP6448847B2 (ja) 腹膜治療液及び腹膜治療液容器
RU2011109921A (ru) Препараты канфосфамида и их получения
WO2007058498A1 (en) Compositions for peritoneal dialysis
JPS6393718A (ja) 注射剤
CN1813795A (zh) 一种药物组合物
JP5371278B2 (ja) 透析用剤およびその製造方法